Articles

MDoutlook® Delivers Precision Intelligence

Having recently named the 2020 leaders in oncology and ImmunoOncology, our latest release from our annual Corporate Leadership report reveals the key attributes oncologists view as driving successful leadership in IO. “Products” and “R&D/Product Pipeline” are the two most important aspects driving oncologists’ view of Corporate Leadership. The top five
Read more
In our latest annual series exploring corporate leaders in oncology (in oncology and IO), oncologists shared their views to reveal BMS (and Celgene), Merck & Co and Roche / Genentech as dominant in oncology and ImmunoOncology. Today’s corporate leaders dominated in 2019 with oncologist preferences showing consistency in their ranking
Read more
ThoughtLeaders in healthcare are individuals who are recognized as experts in their field. They are often thought of as innovators and visionaries, and their insights and perspectives can be highly influential in shaping the direction of the healthcare industry. As such, they can play a significant role in shaping healthcare
Read more
Would you like timely critical insights that enhance your businesses in a competitive marketplace? We’ve engaged 87,000 physicians worldwide in our active community of validated and active treaters that includes valuable Medical Key Opinion Leaders and ThoughtLeaders.
Read more
Immediate Access to Your Target Healthcare ThoughtLeaders It can be a lengthy and challenging process to identify the right healthcare ThoughtLeaders to serve as advocates for pharmaceutical brands. At MDOutlook, we make it easy to identify, engage and deploy Healthcare ThoughtLeaders who can drive value for companies. Our precision engagement
Read more
Measuring the impact of data announcements is of importance, tracking follow-up activity from a conference is of even greater importance and should not be overlooked when assessing the overall influence and reach of your messages. Having helped numerous biopharmaceutical companies track impact from their messaging activities, our experienced team shares
Read more
Whilst the importance of conferences such as ASCO and ASH are acknowledged this mantle is shared more than ever today. ESMOs importance has grown significantly in recent years both in terms of size and diversity of audience as well as its reach as a global platform (e.g. more US healthcare
Read more
Cabazitaxel was presented as an option for men with metastatic castration-resistant prostate cancer (mCRPC) who have progressed after treatment with docetaxel and an androgen signaling-targeted agent according to data presented at ESMO 2019. The results showed a significant survival benefit for Cabazitaxel in third line over enzalutamide or abiraterone where
Read more
MDOutlook empowers confident business decisions with valuable precision insights and actionable intelligence. At the recent 2019 annual meeting of the Association of Residents in Radiation Oncology (ASTRO), one of our clients was interested in recruiting very specific radiation oncologists (recruited to a very tight inclusion criteria) to an event at
Read more
ImmunoOncology (IO) expands the treatment possibilities and provides substantial clinical benefit, especially in patients who had little to no effective treatment options less than a decade ago. IO features prominently at the 2019 annual European Society for Medical Oncology (ESMO) annual congress in Barcelona where agenda items will cover topics
Read more
Having recently named the 2020 leaders in oncology and ImmunoOncology, our latest release from our annual Corporate Leadership report reveals the key attributes oncologists view as driving successful leadership in IO. “Products” and “R&D/Product Pipeline” are the two most important aspects driving oncologists’ view of Corporate Leadership. The top five
Read more
In our latest annual series exploring corporate leaders in oncology (in oncology and IO), oncologists shared their views to reveal BMS (and Celgene), Merck & Co and Roche / Genentech as dominant in oncology and ImmunoOncology. Today’s corporate leaders dominated in 2019 with oncologist preferences showing consistency in their ranking
Read more
ThoughtLeaders in healthcare are individuals who are recognized as experts in their field. They are often thought of as innovators and visionaries, and their insights and perspectives can be highly influential in shaping the direction of the healthcare industry. As such, they can play a significant role in shaping healthcare
Read more
Would you like timely critical insights that enhance your businesses in a competitive marketplace? We’ve engaged 87,000 physicians worldwide in our active community of validated and active treaters that includes valuable Medical Key Opinion Leaders and ThoughtLeaders.
Read more
Immediate Access to Your Target Healthcare ThoughtLeaders It can be a lengthy and challenging process to identify the right healthcare ThoughtLeaders to serve as advocates for pharmaceutical brands. At MDOutlook, we make it easy to identify, engage and deploy Healthcare ThoughtLeaders who can drive value for companies. Our precision engagement
Read more
Measuring the impact of data announcements is of importance, tracking follow-up activity from a conference is of even greater importance and should not be overlooked when assessing the overall influence and reach of your messages. Having helped numerous biopharmaceutical companies track impact from their messaging activities, our experienced team shares
Read more
Whilst the importance of conferences such as ASCO and ASH are acknowledged this mantle is shared more than ever today. ESMOs importance has grown significantly in recent years both in terms of size and diversity of audience as well as its reach as a global platform (e.g. more US healthcare
Read more
Cabazitaxel was presented as an option for men with metastatic castration-resistant prostate cancer (mCRPC) who have progressed after treatment with docetaxel and an androgen signaling-targeted agent according to data presented at ESMO 2019. The results showed a significant survival benefit for Cabazitaxel in third line over enzalutamide or abiraterone where
Read more
MDOutlook empowers confident business decisions with valuable precision insights and actionable intelligence. At the recent 2019 annual meeting of the Association of Residents in Radiation Oncology (ASTRO), one of our clients was interested in recruiting very specific radiation oncologists (recruited to a very tight inclusion criteria) to an event at
Read more
ImmunoOncology (IO) expands the treatment possibilities and provides substantial clinical benefit, especially in patients who had little to no effective treatment options less than a decade ago. IO features prominently at the 2019 annual European Society for Medical Oncology (ESMO) annual congress in Barcelona where agenda items will cover topics
Read more
Having recently named the 2020 leaders in oncology and ImmunoOncology, our latest release from our annual Corporate Leadership report reveals the key attributes oncologists view as driving successful leadership in IO. “Products” and “R&D/Product Pipeline” are the two most important aspects driving oncologists’ view of Corporate Leadership. The top five
Read more
In our latest annual series exploring corporate leaders in oncology (in oncology and IO), oncologists shared their views to reveal BMS (and Celgene), Merck & Co and Roche / Genentech as dominant in oncology and ImmunoOncology. Today’s corporate leaders dominated in 2019 with oncologist preferences showing consistency in their ranking
Read more
ThoughtLeaders in healthcare are individuals who are recognized as experts in their field. They are often thought of as innovators and visionaries, and their insights and perspectives can be highly influential in shaping the direction of the healthcare industry. As such, they can play a significant role in shaping healthcare
Read more
Would you like timely critical insights that enhance your businesses in a competitive marketplace? We’ve engaged 87,000 physicians worldwide in our active community of validated and active treaters that includes valuable Medical Key Opinion Leaders and ThoughtLeaders.
Read more
Immediate Access to Your Target Healthcare ThoughtLeaders It can be a lengthy and challenging process to identify the right healthcare ThoughtLeaders to serve as advocates for pharmaceutical brands. At MDOutlook, we make it easy to identify, engage and deploy Healthcare ThoughtLeaders who can drive value for companies. Our precision engagement
Read more
Measuring the impact of data announcements is of importance, tracking follow-up activity from a conference is of even greater importance and should not be overlooked when assessing the overall influence and reach of your messages. Having helped numerous biopharmaceutical companies track impact from their messaging activities, our experienced team shares
Read more
Whilst the importance of conferences such as ASCO and ASH are acknowledged this mantle is shared more than ever today. ESMOs importance has grown significantly in recent years both in terms of size and diversity of audience as well as its reach as a global platform (e.g. more US healthcare
Read more
Cabazitaxel was presented as an option for men with metastatic castration-resistant prostate cancer (mCRPC) who have progressed after treatment with docetaxel and an androgen signaling-targeted agent according to data presented at ESMO 2019. The results showed a significant survival benefit for Cabazitaxel in third line over enzalutamide or abiraterone where
Read more
MDOutlook empowers confident business decisions with valuable precision insights and actionable intelligence. At the recent 2019 annual meeting of the Association of Residents in Radiation Oncology (ASTRO), one of our clients was interested in recruiting very specific radiation oncologists (recruited to a very tight inclusion criteria) to an event at
Read more
ImmunoOncology (IO) expands the treatment possibilities and provides substantial clinical benefit, especially in patients who had little to no effective treatment options less than a decade ago. IO features prominently at the 2019 annual European Society for Medical Oncology (ESMO) annual congress in Barcelona where agenda items will cover topics
Read more
Three Ways to Identify and Activate ThoughtLeaders

3 Ways To Identify And Activate ThoughtLeaders Webinar

In this webinar, we will help you (1) go deeper in identifying your ThoughtLeaders in a specific disease area, (2) to target your ThoughtLeaders for the right type of activity and (3) provide you the foundation for building stronger relationships with specific ThoughtLeaders and their influence networks.

Read More »
Webinar Cover

Performance Tracking To Stay Ahead Of The Curve On-Demand Webinar

You need brand and market insights yesterday! You are not satisfied with the insights provided because each time you receive them, they are out of date. You want to stay one step ahead. In this webinar, we share ways that you can stay ahead by reacting in time through informed confident business decisions.

Read More »